Carvedilol Reduces Exercise-Induced Hyperventilation: A Benefit in Normoxia and a Problem with Hypoxia
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aims: To evaluate whether carvedilol influences exercise hyperventilation and the ventilatory response to hypoxia in heart failure (HF). Methods and results: Fifteen HF patients participated to this double blind, randomised, placebo controlled, cross-over study. Patients were evaluated by quality of life questionnaire, echocardiography, pulmonary function and cardiopulmonary exercise tests (ramp and constant workload) both in normoxia (FiO2=21%) and hypoxia (FiO2=16%, equivalent to a simulated altitude of 2000m). Carvedilol improved clinical condition and reduced left ventricle size, but had no effect on lung mechanics. In normoxia during exercise, ventilation was lower, VCO2 unchanged and PaCO2 (constant workload) or PetCO2 (ramp) higher with carvedilol, exercise capacity was unchanged (peak workload 92±22 and 90±22W for placebo and carvedilol, respectively). Abnormal VE/VCO2 slope was reduced by carvedilol. Hypoxia increased ventilation but less with carvedilol; exercise capacity decreased to 87±21W (placebo) and to 80±11W (carvedilol, p<0.01). With hypoxia, carvedilol decreased VE/VCO2 slope. At constant workload exercise with hypoxia, PaO2 decreased to 69±6 mm Hg (placebo) and to 64±5 (carvedilol, p<0.01). Conclusion: Carvedilol reduced hyperventilation possibly by reducing peripheral chemoreflex sensitivity as suggested by PaCO2 increase with normoxia and PaO2 decrease with hypoxia without VCO2 and VD/VT changes. Lessening hyperventilation is beneficial when breathing normally, but detrimental when hyperventilation is needed for exercise at high altitude.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
A new method for detecting anaerobic threshold by gas exchange
Beaver, W. L., Wasserman, K., & Whipp, B. J. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.6.2020 · Cited by 4,103
Packer, M., Fowler, M. B., Roecker, E. B., Coats, A. J. S., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Staiger, C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035653.72855.bf · Cited by 1,364 · cited 1×
“The carvedilol titration period lasted 2months [ 15 ,18] and was performed by an investigator who did not participate in any other part of the investigation.”
Method
Cited by
Effect of Altitude on the Heart and the Lungs
Bärtsch, P., & Gibbs, J. S. R. (2007) · Circulation · doi:10.1161/circulationaha.106.650796 · Cited by 483
Arena, R., Myers, J., & Guazzi, M. (2008) · Heart Failure Reviews · doi:10.1007/s10741-007-9067-5 · Cited by 268
Why does chronic heart failure cause breathlessness and fatigue?
Witte, K. K., & Clark, A. L. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.003 · Cited by 135
Comportamento do ergorreflexo na insuficiência cardíaca
Belli, J. F. C., Bacal, F., Bocchi, E. A., & Guimarães, G. V. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000072 · Cited by 24
Metadata
- Authors
- Agostoni, P., Contini, M., Magini, A., Apostolo, A., Cattadori, G., Bussotti, M., Veglia, F., Andreini, D., & Palermo, P.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10-28
- Volume
- 8
- Issue
- 7
- Pages
- 729-735
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2039931321
- Cited by
- 63
- References
- 3
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carvedilol Reduces Exercise-Induced Hyperventilation: A Benefit in Normoxia and a Problem with Hypoxia. https://app.cochat.ai/papers/10.1016/j.ejheart.2006.02.001
- The paper
- Agostoni, P., Contini, M., Magini, A., Apostolo, A., Cattadori, G., Bussotti, M., Veglia, F., Andreini, D., & Palermo, P. (2006). Carvedilol Reduces Exercise-Induced Hyperventilation: A Benefit in Normoxia and a Problem with Hypoxia. European Journal of Heart Failure. https://doi.org/10.1016/j.ejheart.2006.02.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.